Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors
2022 StandoutNobel
Aerosol Deposition in Health and Disease
2012
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Effects of Marijuana Smoking on the Lung
2013
Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors
2001
Coronavirus biology and replication: implications for SARS-CoV-2
2020 Standout
Positron emission tomography and gene therapy: basic concepts and experimental approaches for gene expression imaging
2004
Biofilms and antibiotic therapy: Is there a role for combating bacterial resistance by the use of novel drug delivery systems?
2005
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature
2015
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Control of repeat-protein curvature by computational protein design
2015 StandoutNobel
Engineered protein scaffolds as next-generation antibody therapeutics
2009
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
2020
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
Adverse Health Effects of Marijuana Use
2014 Standout
An overview of environmental risk factors in systemic sclerosis
2015
Cystic fibrosis
2016 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Relationship of Adverse Events to Serum Drug Levels in Patients Receiving High-Dose Azithromycin for Mycobacterial Lung Disease
1997
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease
2006
Cystic Fibrosis Sputum DNA Has NETosis Characteristics and Neutrophil Extracellular Trap Release Is Regulated by Macrophage Migration-Inhibitory Factor
2014
In Vitro Aerosol Delivery and Regional Airway Surface Liquid Concentration of a Liposomal Cationic Peptide
2001
Azithromycin Activity Against Mycobacterium avium Complex Lung Disease in Patients Who Were Not Infected with Human Immunodeficiency Virus
1996
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
2001
Alternative non-antibody scaffolds for molecular recognition
2007
In vitro antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus☆
2009 StandoutNobel
Molecular Mechanisms of Clarithromycin Resistance in Mycobacterium avium: Observation of Multiple 238 rDNA Mutations in a Clonal Population
1996
Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment
2003
Treatment of Mycobacterium avium-intracellulare complex Lung Disease With a Macrolide, Ethambutol, and Clofazimine
2003
Systemic sclerosis
2017 Standout
Mycobacterial lung disease in cystic fibrosis: a prospective study
1997
Minocycline attenuates gentamicin induced hair cell loss in neonatal cochlear cultures
2004
Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit
2005
Scleroderma
2009 Standout
Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis
2015
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase
2004
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Non-alcoholic fatty liver disease
2021 Standout
Graves' Ophthalmopathy
2010 Standout
Neutrophil extracellular traps in immunity and disease
2017 Standout
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
2011
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets
2018
Marijuana: Respiratory Tract Effects
2013
Mediators of Chronic Obstructive Pulmonary Disease
2004
Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases
2012
Surgery for Mycobacterium avium complex lung disease in the clarithromycin era
2002
Interpretative strategies for lung function tests
2005 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 Standout
Aerosol Deposition of Lipid Complex Amphotericin-B (Abelcet) in Lung Transplant Recipients
2006
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?
2020
Reducing implant-related infections: active release strategies
2006 Standout
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
2019
The role of ribosomal RNAs in macrolide resistance
1997
Environmental risk factors of systemic sclerosis
2015
Paclitaxel Nano-Delivery Systems: A Comprehensive Review
2013
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
2015
Quandary about treatment of aspergillomas persists
1996
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
2007
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
2003
Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis
2007
DLS and zeta potential – What they are and what they are not?
2016 Standout
DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti–topoisomerase I autoantibodies from systemic sclerosis patients
2006
Smoked Marijuana as a Cause of Lung Injury
2005
Antibiotic and Anti-Inflammatory Therapies for Cystic Fibrosis
2013
Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
2017
Effect of Clarithromycin Regimen for Mycobacterium avium Complex Pulmonary Disease
1999
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
2019 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
23S rRNA 2058A→G Alteration Mediates Ketolide Resistance in Combination with Deletion in L22
2006 StandoutNobel
Comparison of Cascade Impaction and Laser Diffraction for Particle Size Distribution Measurements
2005
Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
2006
Advances in Transition Metal (Pd,Ni,Fe)-Catalyzed Cross-Coupling Reactions Using Alkyl-organometallics as Reaction Partners
2011 Standout
Immunology of Psoriasis
2014 Standout
Release of Cystic Fibrosis Airway Inflammatory Markers from Pseudomonas aeruginosa–Stimulated Human Neutrophils Involves NADPH Oxidase-Dependent Extracellular DNA Trap Formation
2014
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
2018 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
2021
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
Systemic Antifungal Agents
1998
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Epidemiology of infection by nontuberculous mycobacteria
1996
The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung
2015
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
2015
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus
1996
2020 Standout
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Airborne transmission of respiratory viruses
2021 StandoutScience
The Effect of Combined Therapy According to the Guidelines for the Treatment of Mycobacterium avium Complex Pulmonary Disease
2003
Works of P. Diot being referenced
Aerosolized Chemotherapy
2008
Aerosolized Gemcitabine in Patients with Carcinoma of the Lung: Feasibility and Safety Study
2011
Relationship Between Abnormalities on High-Resolution CT and Pulmonary Function in Systemic Sclerosis
1998
The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors
2011
What the pulmonary specialist should know about the new inhalation therapies
2011
EPI-hNE4, a Proteolysis-Resistant Inhibitor of Human Neutrophil Elastase and Potential Anti-Inflammatory Drug for Treating Cystic Fibrosis
2006
Pneumorachis and pneumomediastinum caused by repeated Müller's maneuvers: Complications of marijuana smoking
2001
Deposition of amphotericin B aerosols in pulmonary aspergilloma
1995
Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis
2001
Comorbidities of COPD
2013
Systemic sclerosis and occupational risk factors: a case–control study
2002
Clarithromycin in the Treatment of Mycobacterium avium Lung Infections in Patients Without AIDS
1995
Lipid nanocapsules: Ready-to-use nanovectors for the aerosol delivery of paclitaxel
2009
Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system
2014
European Respiratory Society Guidelines on the use of nebulizers
2001
Possible Interaction between Phenobarbital, Carbamazepine and Itraconazole
1993
Nebulization as a delivery method for mAbs in respiratory diseases
2015
Is Anti-Topoisomerase I a Serum Marker of Pulmonary Involvement in Systemic Sclerosis?
1999
Poly- l -Lysine Compacts DNA, Kills Bacteria, and Improves Protease Inhibition in Cystic Fibrosis Sputum
2013
RhDNase I Aerosol Deposition and Related Factors in Cystic Fibrosis
1997
Influence of DNA on the Activities and Inhibition of Neutrophil Serine Proteases in Cystic Fibrosis Sputum
2012
Radioisotopic Imaging Allows Optimization of Adenovirus Lung Deposition for Cystic Fibrosis Gene Therapy
2001
Aerosols and Anti-Infectious Agents
2001
Predictive value of serum III procollagen for diagnosis of pulmonary involvement in patients with scleroderma
1995
Validation of Laser Diffraction Method as a Substitute for Cascade Impaction in the European Project for a Nebulizer Standard
2001
Characteristics of EPI-hNE4 Aerosol: A New Elastase Inhibitor for Treatment of Cystic Fibrosis
2003
Residual Gravimetric Method to Measure Nebulizer Output
2004
[Serum procalcitonin and respiratory tract infections].
1999